These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 24226935

  • 1. The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.
    Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Robertson M, Castle PE, New Mexico HPV Pap Registry Steering Committee.
    Int J Cancer; 2014 Aug 01; 135(3):624-34. PubMed ID: 24226935
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF.
    Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):232-238. PubMed ID: 29575846
    [Abstract] [Full Text] [Related]

  • 3. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F, Yan P, Huang X, Wang C, Du H, Qu X, Wu R.
    BMC Cancer; 2022 Jan 06; 22(1):42. PubMed ID: 34991494
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
    Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M.
    J Natl Cancer Inst; 2005 Jul 20; 97(14):1072-9. PubMed ID: 16030305
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.
    Uijterwaal MH, Polman NJ, Witte BI, van Kemenade FJ, Rijkaart D, Berkhof J, Balfoort-van der Meij GA, Ridder R, Snijders PJ, Meijer CJ.
    Int J Cancer; 2015 May 15; 136(10):2361-8. PubMed ID: 25345358
    [Abstract] [Full Text] [Related]

  • 9. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL, Hu SY, Zhang Q, Dong L, Feng RM, Han R, Zhao FH.
    J Gynecol Oncol; 2017 Jul 15; 28(4):e30. PubMed ID: 28541628
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
    Safaeian M, Solomon D, Wacholder S, Schiffman M, Castle P.
    Obstet Gynecol; 2007 Jun 15; 109(6):1325-31. PubMed ID: 17540804
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.
    Castle PE, Shaber R, LaMere BJ, Kinney W, Fetterma B, Poitras N, Lorey T, Schiffman M, Dunne A, Ostolaza JM, McKinney S, Burk RD.
    Cancer Epidemiol Biomarkers Prev; 2011 May 15; 20(5):946-53. PubMed ID: 21415357
    [Abstract] [Full Text] [Related]

  • 13. Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial.
    Smelov V, Elfström KM, Johansson AL, Eklund C, Naucler P, Arnheim-Dahlström L, Dillner J.
    Int J Cancer; 2015 Mar 01; 136(5):1171-80. PubMed ID: 25043476
    [Abstract] [Full Text] [Related]

  • 14. PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.
    Kang Y, Sun P, Mao X, Dong B, Ruan G, Chen L.
    J Gynecol Oncol; 2019 May 01; 30(3):e29. PubMed ID: 30887754
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK, Frederiksen K, Munk C, Iftner T.
    J Natl Cancer Inst; 2010 Oct 06; 102(19):1478-88. PubMed ID: 20841605
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical Precancers.
    Castle PE, Pierz AJ, Adcock R, Aslam S, Basu PS, Belinson JL, Cuzick J, El-Zein M, Ferreccio C, Firnhaber C, Franco EL, Gravitt PE, Isidean SD, Lin J, Mahmud SM, Monsonego J, Muwonge R, Ratnam S, Safaeian M, Schiffman M, Smith JS, Swarts A, Wright TC, Van De Wyngard V, Xi LF.
    Cancer Prev Res (Phila); 2020 Oct 06; 13(10):829-840. PubMed ID: 32655005
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.